Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of <i>JAK2</i> V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation

<div>(a) CT showing left periorbital myeloid sarcoma (arrowed); (b) periorbital biopsy showing blast infiltration by myeloid sarcoma (Hematoxylin and Eosin; magnification ×40); (c) positive immunohistochemical staining for CD34 in the myeloid sarcoma (magnification ×40).</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of <i>JAK2</i> V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation 

Figure 1 | Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation 